At the same time, many other studies have documented the link between higher immune score or greater lymphocyte infiltration (especially CD8) with better overall survival in patients with advanced cervical cancer, and with regressing disease—in patients with high-grade intraepithelial lesions, supporting an important role of lymphocyte-mediated immunity for controlling the disease [111,121,122]. This evidence concerns the gene CD8A and cervical cancer.